Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19.

Santos, Arnoldo; Martínez-Milla, Juan; Pérez-Calvo, César; Ibáñez, Borja

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19.

Santos, Arnoldo; Martínez-Milla, Juan; Pérez-Calvo, César; Ibáñez, Borja.

J Am Coll Cardiol ; 79(1): e13-e14, 2022 01 04.

Article in English | MEDLINE | ID: covidwho-1587447

Subject(s)

COVID-19; Metoprolol; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Humans; SARS-CoV-2

Fulltext

Print

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Metoprolol Limits: Humans Language: English Journal: J Am Coll Cardiol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Metoprolol Limits: Humans Language: English Journal: J Am Coll Cardiol Year: 2022 Document Type: Article